219 related articles for article (PubMed ID: 31860018)
1. Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia.
Liu AJ; Staffaroni AM; Rojas-Martinez JC; Olney NT; Alquezar-Burillo C; Ljubenkov PA; La Joie R; Fong JC; Taylor J; Karydas A; Ramos EM; Coppola G; Boxer AL; Rabinovici GD; Miller BL; Kao AW
JAMA Neurol; 2020 Mar; 77(3):358-366. PubMed ID: 31860018
[TBL] [Abstract][Full Text] [Related]
2. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
[TBL] [Abstract][Full Text] [Related]
3. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
De Vocht J; Blommaert J; Devrome M; Radwan A; Van Weehaeghe D; De Schaepdryver M; Ceccarini J; Rezaei A; Schramm G; van Aalst J; Chiò A; Pagani M; Stam D; Van Esch H; Lamaire N; Verhaegen M; Mertens N; Poesen K; van den Berg LH; van Es MA; Vandenberghe R; Vandenbulcke M; Van den Stock J; Koole M; Dupont P; Van Laere K; Van Damme P
JAMA Neurol; 2020 Aug; 77(8):1008-1017. PubMed ID: 32421156
[TBL] [Abstract][Full Text] [Related]
4. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
5. Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation.
Liu AJ; Lusk JB; Ervin J; Burke J; O'Brien R; Wang SJ
Acta Neuropathol Commun; 2022 Mar; 10(1):27. PubMed ID: 35241183
[TBL] [Abstract][Full Text] [Related]
6. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
de Vries PJ; Whittemore VH; Leclezio L; Byars AW; Dunn D; Ess KC; Hook D; King BH; Sahin M; Jansen A
Pediatr Neurol; 2015 Jan; 52(1):25-35. PubMed ID: 25532776
[TBL] [Abstract][Full Text] [Related]
8. Predominant subcortical accumulation of
Cho H; Seo SW; Choi JY; Lee HS; Ryu YH; Lee MS; Na DL; Kim HJ; Lyoo CH
Neurobiol Aging; 2018 Jun; 66():112-121. PubMed ID: 29554554
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
11. Distinct Subtypes of Behavioral Variant Frontotemporal Dementia Based on Patterns of Network Degeneration.
Ranasinghe KG; Rankin KP; Pressman PS; Perry DC; Lobach IV; Seeley WW; Coppola G; Karydas AM; Grinberg LT; Shany-Ur T; Lee SE; Rabinovici GD; Rosen HJ; Gorno-Tempini ML; Boxer AL; Miller ZA; Chiong W; DeMay M; Kramer JH; Possin KL; Sturm VE; Bettcher BM; Neylan M; Zackey DD; Nguyen LA; Ketelle R; Block N; Wu TQ; Dallich A; Russek N; Caplan A; Geschwind DH; Vossel KA; Miller BL
JAMA Neurol; 2016 Sep; 73(9):1078-88. PubMed ID: 27429218
[TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.
Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M
Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907
[TBL] [Abstract][Full Text] [Related]
13. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory.
Ljubenkov PA; Staffaroni AM; Rojas JC; Allen IE; Wang P; Heuer H; Karydas A; Kornak J; Cobigo Y; Seeley WW; Grinberg LT; Spina S; Fagan AM; Jerome G; Knopman D; Boeve BF; Dickerson BC; Kramer J; Miller B; Boxer AL; Rosen HJ
Ann Clin Transl Neurol; 2018 Oct; 5(10):1250-1263. PubMed ID: 30349860
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
Pozueta A; Lage C; García-Martínez M; Kazimierczak M; Bravo M; López-García S; Riancho J; González-Suarez A; Vázquez-Higuera JL; de Arcocha-Torres M; Banzo I; Jiménez-Bonilla J; Berciano J; Rodríguez-Rodríguez E; Sánchez-Juan P
J Alzheimers Dis; 2019; 72(4):1129-1144. PubMed ID: 31683488
[TBL] [Abstract][Full Text] [Related]
16. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.
Nation DA; Edmonds EC; Bangen KJ; Delano-Wood L; Scanlon BK; Han SD; Edland SD; Salmon DP; Galasko DR; Bondi MW;
JAMA Neurol; 2015 May; 72(5):546-53. PubMed ID: 25822631
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
Eratne D; Loi SM; Walia N; Farrand S; Li QX; Varghese S; Walterfang M; Evans A; Mocellin R; Dhiman K; Gupta V; Malpas CB; Collins S; Masters CL; Velakoulis D
Aust N Z J Psychiatry; 2020 Jan; 54(1):57-67. PubMed ID: 31220922
[TBL] [Abstract][Full Text] [Related]
18. Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort.
Krudop WA; Dols A; Kerssens CJ; Prins ND; Möller C; Schouws S; Barkhof F; van Berckel BN; Teunissen CE; van der Flier WM; Scheltens P; Sikkes SA; Stek ML; Pijnenburg YA
Dement Geriatr Cogn Disord; 2016; 41(1-2):16-26. PubMed ID: 26473985
[TBL] [Abstract][Full Text] [Related]
19. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.
Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D
Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545
[TBL] [Abstract][Full Text] [Related]
20. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
